SCHEMBL6245437

SCHEMBL6245437

CCC(CO)Nc1nc(Nc2ccncc2)c2ncn(C(C)C)c2n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 18/20 1.00
CDK2 P24941 17/20 1.00
CDK5R1 Q15078 17/20 1.00
CCNA2 P20248 16/20 1.00
CCNA1 P78396 15/20 1.00
DYRK1A Q13627 15/20 1.00
CDK1 P06493 3/20 0.75
CCNB1 P14635 2/20 0.75
CCNE1 P24864 2/20 0.75
CDK7 P50613 2/20 0.75
CCNH P51946 2/20 0.75
CDK4 P11802 1/20 0.75
CCND1 P24385 1/20 0.75
MAPK1 P28482 1/20 0.75
KDM4E B2RXH2 1/20 0.72
NPC1 O15118 1/20 0.72
POLB P06746 1/20 0.72
MAPT P10636 1/20 0.72
CCNK O75909 1/20 0.70
CDK12 Q9NYV4 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6245433 1.00 CDK5 (1.00) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL22651813 0.91 CDK5 (0.83) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL4501614 0.86 CDK2 (1.00) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL3877470 0.86 CDK2 (1.00) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL25001230 0.85 CDK2 (0.83) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL4502860 0.84 CDK2 (1.00) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL4502851 0.84 CDK2 (1.00) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL28453367 0.84 CDK5 (0.80) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL28453366 0.84 CDK5 (0.80) CDK5CDK2CDK5R1CCNA2CCNA1
SCHEMBL13638194 0.83 CDK5 (0.76) CDK5CDK2CDK5R1CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399446-B1 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LTD (GB) 2005-08-03 EP disclosed